Perioperative Administration of Desmopressin to Subjects With Breast Cancer: A Phase IIa, Dose-Escalation Study

Trial Profile

Perioperative Administration of Desmopressin to Subjects With Breast Cancer: A Phase IIa, Dose-Escalation Study

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Sep 2015

At a glance

  • Drugs Desmopressin (Primary)
  • Indications Breast cancer
  • Focus Adverse reactions
  • Sponsors Elea
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 29 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Mar 2015 Planned End Date changed to 1 Jun 2015, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top